Here's a statement of the obvious: The opinions expressed here are those of the participants, not those of the Mutual Fund Observer. We cannot vouch for the accuracy or appropriateness of any of it, though we do encourage civility and good humor.
Support MFO
Donate through PayPal
Deja vu ? Fidelity Was A Big Second-Quarter Buyer Of Valeant Shares
FYI: Some of the largest mutual fund owners of Valeant Pharmaceuticals International bid adieu to the troubled drug maker in the first half of the year.
The Boston-based mutual-fund giant, which holds Valeant’s stock in a number of its funds, sharply boosted its holdings in the second quarter
Valeant's stock is taking a beating as their reported earnings being questioned while the company is being investigated for their business practice. Is this something that will blow over or double down while the price is good. YTD of Fido Biotech is down 16.8% while Vanguard Health Care is down only 0.1%.
Comments